HDL can alter the tumor microenvironment by modulating lipid content, especially by mediating excess cholesterol removal by ABCA-1, ATP-binding cassette transporter G-1 (ABCG-1), and scavenger receptor class B type 1 (SR-B1) through reverse cholesterol transport. This evidence concerns the gene SCARB1 and neoplasm.